Related Experiment Video
Updated: Aug 17, 2026

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
An evaluation of topical mupirocin in moderately severe primary and secondary skin infections
1Kl Dermatovenerologicka FN, Bratislava, Czechoslovakia.
Abstract:
Five days' treatment with topical mupirocin, applied twice daily, in 36 patients with moderately severe primary and secondary skin infections, resulted in resolution/much improvement of skin lesions in 75.0% of patients and bacterial eradication in 83.9% of cases. Penicillin-resistant and penicillin-sensitive staphylococci were most commonly implicated. No adverse effects were reported in any of the patients treated. Physicians' assessment of cure/improvement was recorded in 91.7% of patients.
Insights
Topical mupirocin effectively treated skin infections in 36 patients over five days. The antibiotic achieved significant lesion improvement in 75% and bacterial eradication in over 83%, with no reported side effects.
Area of Science:
- Dermatology
- Infectious Diseases
- Bacteriology
Background:
- Primary and secondary skin infections pose a significant clinical challenge.
- Bacterial pathogens, particularly staphylococci, are frequently implicated in skin infections.
- Topical antimicrobial agents are a cornerstone of treatment for superficial skin infections.
Purpose of the Study:
- To evaluate the efficacy and safety of topical mupirocin for treating primary and secondary skin infections.
- To assess the rate of clinical resolution and bacterial eradication in patients receiving mupirocin.
- To identify the common bacterial species involved in the treated infections.
Main Methods:
- A study involving 36 patients with moderately severe primary and secondary skin infections.
- Treatment consisted of topical mupirocin applied twice daily for five days.
- Clinical outcomes (lesion resolution/improvement) and bacterial eradication rates were assessed.
Main Results:
- Resolution or much improvement of skin lesions was observed in 75.0% of patients.
- Bacterial eradication was achieved in 83.9% of cases.
- Penicillin-resistant and penicillin-sensitive staphylococci were the most frequently identified pathogens.
Conclusions:
- Topical mupirocin demonstrates high efficacy in treating primary and secondary skin infections.
- The treatment is well-tolerated, with no adverse effects reported in this patient cohort.
- Mupirocin is an effective option for eradicating staphylococcal infections of the skin.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Antimicrobial Effectiveness
Staphylococcal Skin Infections
Acne Infection
Clinical Significance of Antibiotic Resistance

